Fleury S.A. (Brazil)
In research, Fleury S.A. (Brazil) stands highest in Health Sciences (#8,161 of 11,982 worldwide) and Medicine (#7,717 of 10,443 worldwide), 2022–2025.
- World rank, 2022–2025
- #14,968 of 28,054 · #25,171 all time
- Rank in Brazil
- #260 of 714
- Research works
- 701 ▲ 90% vs 2013–17
- Citations
- 7.9k 11.2 per fractional work
- Top-10% rate
- 8.0% record average 16.5%
- Open access
- 61% world 28%
What is Fleury S.A. (Brazil) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #8,161 of 11,982 | 8.7% | 164 | #12508 | |
| MedicineField | #7,717 of 10,443 | 8.8% | 157 | #10273 |
Each strip is that field’s whole ranked pool, with the notch where Fleury S.A. (Brazil) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.
- Immunology and Microbiology 4.3×
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Veterinary 1.3×
- Dentistry 1.1×
- Economics, Econometrics and Finance 0.8×
- Nursing 0.7×
- Health Professions 0.7×
- Neuroscience 0.7×
- Social Sciences 0.3×
- Decision Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Business, Management and Accounting 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Computer Science 0.2×
- Environmental Science 0.1×
- Mathematics 0.1×
- Engineering 0.1×
- Chemistry 0.1×
- Chemical Engineering 0.1×
- Arts and Humanities 0.1×
- Psychology 0.1×
- Materials Science 0.0×
- Physics and Astronomy 0.0×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
Who are the top researchers at Fleury S.A. (Brazil)?
Ranked on the composite score, Bruno Lemos Ferrari, Karina Helena Morais Cardozo and Valdemir Melechco Carvalho lead among researchers whose main affiliation is Fleury S.A. (Brazil).
- 1 Bruno Lemos Ferrari Brazil · #1,051,341 worldwide 13 citations · 22 works
- 2 Karina Helena Morais Cardozo Brazil · #1,067,886 worldwide 22 citations · 16 works
- 3 Valdemir Melechco Carvalho Brazil · #1,173,719 worldwide 22 citations · 20 works
Which keywords describe research at Fleury S.A. (Brazil)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Prognostic Factors, Genetic Mutations, Rituximab, Diagnosis, Treatment, Hematopoietic Stem Cells and Chemotherapy.
- Prenatal Diagnosis
- Gene Expression Profiling
- Autoantibodies
- Cardiovascular Risk
- Minimal Residual Disease
- Mutation
- PET Imaging
- Immune Response
- Acute Myeloid Leukemia
- Precision Medicine
- Lymphoma
- Breast Cancer
- Public Health
- Genomic Aberrations
- Pathogenesis
- Immunotherapy
- Chemotherapy
- Rituximab
- Treatment
- Prognostic Factors
- Epidemiology
- Diagnosis
- Genetic Mutations
- Inflammation
- Quality of Life
- Hematopoietic Stem Cells
- Chronic Lymphocytic Leukemia
- Therapeutic Targets
- Prognosis
- Clinical Practice Guidelines
- Targeted Therapy
- AML
- Metabolic Syndrome
- Vaccine
- Viral Transmission
- Pathophysiology
- Survival Analysis
- Infection
- Cell-Free DNA
- Molecular Profiling
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology28▲ 3.1×77 topics
- Prognostic Factors18▲ 17×12 topics
- Diagnosis11▲ 5.2×30 topics
- Treatment10▲ 3.6×30 topics
- Genetic Mutations10▲ 10×18 topics
- Rituximab10▲ 29×4 topics
- Inflammation10▲ 2.1×35 topics
- Chemotherapy8▲ 5.1×19 topics
- Quality of Life8▲ 2.3×18 topics
- Immunotherapy7▲ 4.3×17 topics
- Hematopoietic Stem Cells7▲ 34×3 topics
- Pathogenesis7▲ 5.8×18 topics
- Chronic Lymphocytic Leukemia7▲ 64×1 topic
- Genomic Aberrations7▲ 64×1 topic
- Therapeutic Targets7▲ 19×2 topics
- Public Health6▲ 1.95×18 topics
- Prognosis6▲ 8.0×8 topics
- Breast Cancer6▲ 11×10 topics
- Clinical Practice Guidelines6▲ 4.7×12 topics
- Lymphoma6▲ 15×4 topics
- Targeted Therapy6▲ 11×5 topics
- Precision Medicine6▲ 5.1×6 topics
- AML5▲ 48×1 topic
- Acute Myeloid Leukemia5▲ 48×1 topic
- Metabolic Syndrome5▲ 2.8×13 topics
- Immune Response5▲ 3.9×14 topics
- Vaccine5▲ 4.9×9 topics
- PET Imaging4▲ 11×4 topics
- Viral Transmission4▲ 13×4 topics
- Mutation4▲ 9.6×3 topics
- Pathophysiology4▲ 6.0×7 topics
- Minimal Residual Disease4▲ 26×2 topics
- Survival Analysis4▲ 6.2×6 topics
- Cardiovascular Risk4▲ 5.3×8 topics
- Infection4▲ 6.6×4 topics
- Autoantibodies4▲ 6.8×8 topics
- Cell-Free DNA4▲ 16×2 topics
- Gene Expression Profiling3▲ 17×2 topics
- Molecular Profiling3▲ 15×3 topics
- Prenatal Diagnosis3▲ 9.8×5 topics
Which research topics does Fleury S.A. (Brazil) publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 7 works
- 2 Acute Myeloid Leukemia Research Hematology 5 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 4 Chronic Myeloid Leukemia Treatments Hematology 3 works
- 5 Cancer Genomics and Diagnostics Cancer Research 2 works
- 6 T-cell and Retrovirus Studies Immunology 2 works
- 7 Nutrition and Health in Aging Physiology 2 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 9 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 10 Multiple Myeloma Research and Treatments Hematology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fleury S.A. (Brazil)'s research output changed?
Output in 2018–2022 was 90% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in São Paulo
- Universidade de São Paulo
- Universidade Estadual Paulista (Unesp)
- Universidade Federal de São Paulo
- Pontifícia Universidade Católica de São Paulo
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Hospital Universitário da Universidade de São Paulo
- Universidade Brasil
- Universidade Presbiteriana Mackenzie
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.